NK cells help induce anti-hepatitis B virus CD8+ T cell immunity in mice

Journal of Immunology

Volumn 196, Issue 10, 2016, Pages 4122-4131

  Zheng, Meijuan ^a,b   Sun, Rui ^a   Wei, Haiming ^a   Tian, Zhigang ^a,c  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTEGRIN; CELL PROTEIN; GAMMA INTERFERON; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; PROTEIN DX5; UNCLASSIFIED DRUG; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CD8 ANTIGEN; HOMEODOMAIN PROTEIN; NFIL3 PROTEIN, MOUSE; RAG-1 PROTEIN; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21; VIRUS ENVELOPE PROTEIN;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPLETION; EFFECTOR CELL; HEPATITIS B; HEPATITIS B VIRUS; HYDRODYNAMICS BASED TRANSFECTION; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MALE; MEMORY T LYMPHOCYTE; MOUSE; MOUSE MODEL; NATURAL KILLER CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIRAL CLEARANCE; ACUTE DISEASE; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; METABOLISM; PHYSIOLOGY; TRANSPLANTATION; VIROLOGY; VIRUS LOAD;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD8; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HOMEODOMAIN PROTEINS; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-BOX DOMAIN PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL LOAD;

EID: 84975048845     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500846     Document Type: Article

References (61)

1. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
2. Martín-Fontecha, A., L. L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-γamma for T(H)1 priming. Nat. Immunol. 5: 1260-1265.
3. Wong, J. L., E. Berk, R. P. Edwards, and P. Kalinski. 2013. IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment. Cancer Res. 73: 4653-4662.
4. Robbins, S. H., G. Bessou, A. Cornillon, N. Zucchini, B. Rupp, Z. Ruzsics, T. Sacher, E. Tomasello, E. Vivier, U. H. Koszinowski, and M. Dalod. 2007. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog. 3: e123.
5. Combe, C. L., T. J. Curiel, M. M. Moretto, and I. A. Khan. 2005. NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells. Infect. Immun. 73: 4913-4921.
6. Nandakumar, S., S. N. Woolard, D. Yuan, B. T. Rouse, and U. Kumaraguru. 2008. Natural killer cells as novel helpers in anti-herpes simplex virus immune response. J. Virol. 82: 10820-10831.
7. Lang, P. A., K. S. Lang, H. C. Xu, M. Grusdat, I. A. Parish, M. Recher, A. R. Elford, S. Dhanji, N. Shaabani, C. W. Tran, et al. 2012. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc. Natl. Acad. Sci. USA 109: 1210-1215.
8. Manjili, M. H., and A. Toor. 2011. Comment on "Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses". J. Immunol. 186: 6071, author reply 6071-6072.
9. Waggoner, S. N., M. Cornberg, L. K. Selin, and R. M. Welsh. 2011. Natural killer cells act as rheostats modulating antiviral T cells. Nature 481: 394-398.
10. Stoop, J. N., R. G. van der Molen, C. C. Baan, L. J. van der Laan, E. J. Kuipers, J. G. Kusters, and H. L. Janssen. 2005. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41: 771-778.
11. Ferrari, C., A. Penna, A. Bertoletti, A. Valli, A. D. Antoni, T. Giuberti, A. Cavalli, M. A. Petit, and F. Fiaccadori. 1990. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145: 3442-3449.
12. Fisicaro, P., C. Valdatta, C. Boni, M. Massari, C. Mori, A. Zerbini, A. Orlandini, L. Sacchelli, G. Missale, and C. Ferrari. 2009. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58: 974-982.
13. Bertoletti, A., and C. Ferrari. 2012. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61: 1754-1764.
14. Sun, C., B. Fu, Y. Gao, X. Liao, R. Sun, Z. Tian, and H. Wei. 2012. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 8: e1002594.
15. Wieland, S., R. Thimme, R. H. Purcell, and F. V. Chisari. 2004. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 101: 6669-6674.
16. Norton, P. A., S. Menne, G. Sinnathamby, L. Betesh, P. J. Cote, R. Philip, A. S. Mehta, B. C. Tennant, and T. M. Block. 2010. Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks. Hepatology 52: 1242-1250.
17. Sherker, A. H., K. Hirota, M. Omata, and K. Okuda. 1986. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks. Gastroenterology 91: 818-824.
18. Moriyama, T., S. Guilhot, K. Klopchin, B. Moss, C. A. Pinkert, R. D. Palmiter, R. L. Brinster, O. Kanagawa, and F. V. Chisari. 1990. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248: 361-364.
19. Purcell, R. H., W. T. London, V. J. McAuliffe, A. E. Palmer, P. M. Kaplan, J. L. Gerin, J. Wagner, H. Popper, E. Lvovsky, D. C. Wong, and H. B. Levy. 1976. Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer. Lancet 2: 757-761.
20. Zeissig, S., K. Murata, L. Sweet, J. Publicover, Z. Hu, A. Kaser, E. Bosse, J. Iqbal, M. M. Hussain, K. Balschun, et al. 2012. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat. Med. 18: 1060-1068.
21. Zeng, Z., X. Kong, F. Li, H. Wei, R. Sun, and Z. Tian. 2013. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier. J. Immunol. 191: 4184-4193.
22. Huang, L. R., H. L. Wu, P. J. Chen, and D. S. Chen. 2006. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 103: 17862-17867.
23. Yang, P. L., A. Althage, J. Chung, H. Maier, S. Wieland, M. Isogawa, and F. V. Chisari. 2010. Immune effectors required for hepatitis B virus clearance. Proc. Natl. Acad. Sci. USA 107: 798-802.
24. Sun, R., and B. Gao. 2004. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology 127: 1525-1539.
25. Yang, P. L., A. Althage, J. Chung, and F. V. Chisari. 2002. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 99: 13825-13830.
26. Xu, L., W. Yin, R. Sun, H. Wei, and Z. Tian. 2013. Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice. Proc. Natl. Acad. Sci. USA 110: 16993-16998.
27. Xu, L., W. Yin, R. Sun, H. Wei, and Z. Tian. 2014. Kupffer cell-derived IL-10 plays a key role in maintaining humoral immune tolerance in hepatitis B viruspersistent mice. Hepatology 59: 443-452.
28. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13: 29-60.
29. Thimme, R., S. Wieland, C. Steiger, J. Ghrayeb, K. A. Reimann, R. H. Purcell, and F. V. Chisari. 2003. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77: 68-76.
30. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4: 25-36.
31. Wherry, E. J., V. Teichgräber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
32. Kakimi, K., L. G. Guidotti, Y. Koezuka, and F. V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192: 921-930.
33. Andrews, D. M., M. J. Estcourt, C. E. Andoniou, M. E. Wikstrom, A. Khong, V. Voigt, P. Fleming, H. Tabarias, G. R. Hill, R. G. van der Most, et al. 2010. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 207: 1333-1343.
34. Assarsson, E., T. Kambayashi, J. K. Sandberg, S. Hong, M. Taniguchi, L. Van Kaer, H. G. Ljunggren, and B. J. Chambers. 2000. CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J. Immunol. 165: 3673-3679.
35. Trambley, J., A. W. Bingaman, A. Lin, E. T. Elwood, S. Y. Waitze, J. Ha, M. M. Durham, M. Corbascio, S. R. Cowan, T. C. Pearson, and C. P. Larsen. 1999. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. 104: 1715-1722.
36. Kosaka, A., D. Wakita, N. Matsubara, Y. Togashi, S. Nishimura, H. Kitamura, and T. Nishimura. 2007. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-γamma-dependent type 1 immunity. Int. Immunol. 19: 249-256.
37. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19: 65-91.
38. Phillips, S., S. Chokshi, A. Riva, A. Evans, R. Williams, and N. V. Naoumov. 2010. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J. Immunol. 184: 287-295.
39. Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825-829.
40. Guidotti, L. G., K. Ando, M. V. Hobbs, T. Ishikawa, L. Runkel, R. D. Schreiber, and F. V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91: 3764-3768.
41. Lefrançois, L. 2006. Development, trafficking, and function of memory T-cell subsets. Immunol. Rev. 211: 93-103.
42. Ge, M. Q., A. W. Ho, Y. Tang, K. H. Wong, B. Y. Chua, S. Gasser, and D. M. Kemeny. 2012. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms. J. Immunol. 189: 2099-2109.
43. Mailliard, R. B., Y. I. Son, R. Redlinger, P. T. Coates, A. Giermasz, P. A. Morel, W. J. Storkus, and P. Kalinski. 2003. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J. Immunol. 171: 2366-2373.
44. Racanelli, V., and B. Rehermann. 2006. The liver as an immunological organ. Hepatology 43(2, Suppl 1): S54-S62.
45. Crispe, I. N. 2009. The liver as a lymphoid organ. Annu. Rev. Immunol. 27: 147-163.
46. Zheng, M., J. Yu, and Z. Tian. 2013. Characterization of the liver-draining lymph nodes in mice and their role in mounting regional immunity to HBV. Cell. Mol. Immunol. 10: 143-150.
47. Mandaric, S., S. M. Walton, T. Rülicke, K. Richter, M. J. Girard-Madoux, B. E. Clausen, A. Zurunic, M. Kamanaka, R. A. Flavell, S. Jonjic, and A. Oxenius. 2012. IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMVspecific CD4 T cells and prolonged MCMVpersistence. PLoS Pathog. 8: e1002846.
48. Dunn, C., D. Peppa, P. Khanna, G. Nebbia, M. Jones, N. Brendish, R. M. Lascar, D. Brown, R. J. Gilson, R. J. Tedder, et al. 2009. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137: 1289-1300.
49. Li, M., R. Sun, L. Xu, W. Yin, Y. Chen, X. Zheng, Z. Lian, H. Wei, and Z. Tian. 2015. Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Ex-haustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice. J. Immunol. 195: 3100-3109.
50. Asabe, S., S. F. Wieland, P. K. Chattopadhyay, M. Roederer, R. E. Engle, R. H. Purcell, and F. V. Chisari. 2009. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J. Virol. 83: 9652-9662.
51. Schuch, A., A. Hoh, and R. Thimme. 2014. The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection. Front. Immunol. 5: 258.
52. Van Elssen, C. H., T. Oth, W. T. Germeraad, G. M. Bos, and J. Vanderlocht. 2014. Natural killer cells: the secret weapon in dendritic cell vaccination strategies. Clin. Cancer Res. 20: 1095-1103.
53. Maini, M. K., and D. Peppa. 2013. NK cells: a double-edged sword in chronic hepatitis B virus infection. Front. Immunol. 4: 57.
54. Chen, Y., H. Wei, B. Gao, Z. Hu, S. Zheng, and Z. Tian. 2005. Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J. Viral Hepat. 12: 38-45.
55. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
56. Biron, C. A., and L. Brossay. 2001. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13: 458-464.
57. Bouwer, A. L., S. C. Saunderson, F. J. Caldwell, T. T. Damani, S. J. Pelham, A. C. Dunn, R. W. Jack, P. Stoitzner, and A. D. McLellan. 2014. NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge. J. Immunol. 192: 2514-2521.
58. Guy, C. S., P. M. Mulrooney-Cousins, N. D. Churchill, and T. I. Michalak. 2008. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J. Virol. 82: 8579-8591.
59. Tjwa, E. T., G. W. van Oord, J. P. Hegmans, H. L. Janssen, and A. M. Woltman. 2011. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J. Hepatol. 54: 209-v218.
60. Ju, Y., N. Hou, J. Meng, X. Wang, X. Zhang, D. Zhao, Y. Liu, F. Zhu, L. Zhang, W. Sun, et al. 2010. T cell immunoglobulin-and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J. Hepatol. 52: 322-329.
61. Li, F., H. Wei, H. Wei, Y. Gao, L. Xu, W. Yin, R. Sun, and Z. Tian. 2013. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. Gastroenterology 144: 392-401.